Peiyue Wu on Muck Rack

Peiyue Wu

New York
As seen in: Wiley Online Library, Chemical & Engineering News (C&EN), Scroll.in, Optica, Rest of World, The Wire China, Art Spiel
Slow writer, hard thinker 🕵🏻👩🏻‍💻 for Sixth Tone, Rest of World, Tech in Asia, Caixin Global.

Get in touch with Peiyue

Contact Peiyue, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

China’s Next AI Challenge: Controlling the Cost

|
By Peiyue Wu
| The Wire China Verified
Alibaba's Qwen AI foundation model exhibition booth at the 2025 Apsara Conference, hosted by Alibaba Cloud, in Hangzhou, China, from September 24–26, 2025. Credit: Alibaba From sector to sector, Chinese companies have come to dominate global industry through their ability to export mass quantities of low-cost products. The world of AI may prove harder to conquer with the same trick.
Open in Who Shared Issue with article?

China’s Delivery Revolution

|
By Peiyue Wu
| The Wire China Verified
A Meituan autonomous delivery vehicle carrying orders runs along a road next to a Meituan human courier, in Beijing, China, April 8, 2020. Credit: VCG via Getty Images On the streets of Beijing’s Shunyi district, Meituan’s squat yellow delivery robots have been shuttling groceries and takeout since 2020. Looking like miniature vans, the vehicles roll slowly along the curb with two side doors that lift open to reveal packed orders.
Open in Who Shared Issue with article?

Albumin made from rice could be game changing. But can the start-up that makes it survive?

|
By Peiyue Wu
| Chemical & Engineering News (C&EN) Verified
Human serum albumin (HSA)-a plasma-derived protein used to treat patients with cirrhosis, liver failure, burns, and other severe conditions-is China's top-selling hospital drug, yet most of it still comes from North American and European firms. Now a biotech start-up in the country has found an alternative source of albumin: rice. On July 18, Chinese regulators approved the world's first plant-derived recombinant HSA (rHSA) for therapeutic use, developed by Wuhan Healthgen Biotechnology.
Open in Who Shared Issue with article?
See all 12 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified